selectivity comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor type 1a, the same G protein-coupled receptor that binds ghrelin. Receptor activation couples to Gq/11 signaling, raising intracellular calcium through inositol trisphosphate and diacylglycerol, which in turn promotes exocytosis of growth hormone from pituitary somatotroph cells. Ipamorelin binds this receptor with high affinity and shows weak activity at other secretagogue-related targets in vitro. Its action requires the intact receptor and is not reversed by growth hormone-releasing hormone antagonists.
Compared with earlier growth hormone secretagogues such as GHRP-6 and hexarelin, ipamorelin has been reported to produce less stimulation of adrenocorticotropic hormone, cortisol, and prolactin in animal and early human studies. This selectivity is usually attributed to differences in receptor subtype interactions and to the tissue distribution of the receptor. Effects on appetite appear weaker than those of ghrelin itself, although the supporting evidence base is small. Whether these differences produce a distinct clinical profile remains an open question, since controlled human trials are limited.
Ipamorelin is a synthetic pentapeptide first described in the 1990s by researchers at Novo Nordisk during a program to develop selective growth hormone secretagogues. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues, alpha-aminoisobutyric acid and D-2-naphthylalanine. The C-terminus is amidated, and the material is supplied as a white lyophilized powder. The molecular formula is C38H49N9O5 and the monoisotopic mass is approximately 711.85 daltons. The short chain and modified residues give it greater resistance to enzymatic degradation than many larger peptide hormones.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues that resist enzymatic breakdown. Researchers at Novo Nordisk described the compound in the 1990s while searching for agents that release growth hormone with fewer side effects than earlier secretagogues. The molecule acts as an agonist at the ghrelin receptor, also called GHS-R1a, which is expressed in the pituitary and in several peripheral tissues.
Selectivity distinguishes ipamorelin from first-generation secretagogues such as GHRP-6. At doses that reliably raise growth hormone, it shows little stimulation of adrenocorticotropic hormone or cortisol release in animal models, and it does not markedly raise prolactin or appetite. Binding at GHS-R1a on pituitary somatotrophs triggers calcium influx and pulsatile growth hormone secretion. Because the compound mimics the natural ghrelin signal, the release pattern tends to follow the body's own rhythm rather than producing a sustained elevation.
Most published work on ipamorelin comes from rodent studies and small early-phase human trials. Subcutaneous and intravenous routes have been used, while oral delivery is limited by poor absorption and rapid breakdown in the gut. The reported plasma half-life is short, on the order of two hours, and varies with species and assay method. Whether chronic use produces meaningful clinical benefit remains unresolved, and long-term safety data in humans are sparse. No major regulatory agency has approved the compound as a therapeutic drug.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H49N9O5 | Pentapeptide with amidated C-terminus |
| Molecular weight | 711.85 g/mol | Monoisotopic mass |
| Primary receptor | GHS-R1a | Ghrelin receptor, Gq/11 coupled |
| Peptide class | Synthetic pentapeptide | Contains two non-natural residues |
| Reported selectivity | Lower cortisol and prolactin effect | Observed in animal and early human work |
The compound was developed at Novo Nordisk during the 1990s as part of a programme seeking secretagogues with improved selectivity. It was described in the peer-reviewed literature in 1998 alongside related pentapeptides from the same series. Investigators advanced it because it raised growth hormone output in animal models while leaving other pituitary hormones comparatively unaffected. The development code NNC 26-0161 appears in earlier reports, and ipamorelin later became the common designation in published work.
Selectivity is the property most often attached to this peptide. Published animal and early human studies record increases in growth hormone release after administration, with adrenocorticotropic hormone and cortisol responses remaining small by comparison. Effects on appetite-related pathways also appear weaker than those reported for several earlier secretagogues. Reviews that compare members of the growth hormone secretagogue family cite these findings frequently, though the receptor-level explanation for the selectivity continues to be debated rather than settled.
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.
Analytical confirmation relies on reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry for identity and purity assessment. Mass spectrometry distinguishes the intact molecule from truncation products and from oxidation or deamidation variants that share similar chromatographic retention. Immunoassays appear in some biological studies but can cross-react with related peptides, so they are weaker tools for identity work. Reported purity figures depend heavily on the gradient, detector, and integration method used, which complicates direct comparison between laboratories.
Research quantities of ipamorelin are typically distributed as a white to off-white lyophilized powder. The solid dissolves readily in water and in aqueous buffers, and stock solutions are commonly prepared in sterile water or a mildly acidic diluent. Adsorption to plastic and glass surfaces can reduce the concentration of very dilute solutions, so containers and transfer steps deserve attention when accurate concentrations matter. Reconstituted material is generally used promptly rather than held for extended periods.
Storage recommendations for the dry solid center on low temperature and low moisture, most often -20 °C in a sealed, desiccated container protected from light. Solutions are less stable than the powder and are usually kept cold and used within a short window. Freeze-thaw cycling is a recognized source of loss, and aliquoting before freezing is a standard precaution. These practices derive from general peptide handling principles rather than from a single published stability trial, so exact shelf lives should be treated as approximate.
Common solvents for laboratory work include water, buffered saline, and dimethyl sulfoxide. Once dissolved, the peptide is exposed to hydrolysis and oxidation, and alkaline conditions accelerate breakdown. Low-binding plasticware and the addition of a carrier protein reduce losses to container surfaces, which can otherwise be substantial at low concentrations. Solutions are typically kept cold and used within days. Investigators working with the compound generally prepare fresh working dilutions rather than storing dilute stocks, and they avoid repeated warming of the same vial.
Reversed-phase high-performance liquid chromatography is the standard method for purity assessment, most often on a C18 column with a water and acetonitrile gradient and trifluoroacetic acid or formic acid as an ion-pairing agent. Mass spectrometry by electrospray or matrix-assisted laser desorption confirms the expected mass and reveals truncated or modified sequences. Amino acid analysis and sequencing provide orthogonal structural evidence. Typical impurities include deletion sequences, oxidized products, and dimeric species. Detection wavelength, usually 214 or 220 nanometers, should be reported because response factors differ between peptides.
Gaddafi was later infuriated when Egypt and Syria planned the Yom Kippur War against Israel without consulting him and was angered when Egypt conceded to peace talks rather than continuing the war. Gaddafi became openly hostile to Egypt's leader, calling for Sadat's overthrow. When Sudanese President Gaafar Nimeiry took Sadat's side, Gaddafi also spoke out against him, encouraging the Sudan People's Liberation Army's attempt to overthrow Nimeiry. In 1974, Gaddafi released Abdul-Aziz Shennib, a commander under King Idris, from prison and appointed him Libyan ambassador to Jordan. Shennib had attended the Royal Military Academy Sandhurst with King Hussein of Jordan and was tasked by Gaddafi with Hussein's assassination. Shennib instead informed Hussein of the plot and defected to Jordan. Relations with Syria also soured over the events in the Lebanese Civil War. Initially, both Libya and Syria had contributed troops to the Arab League's peacekeeping force, although after the Syrian army attacked the Lebanese National Movement, Gaddafi openly accused Syrian President Hafez al-Assad of "national treason"; he was the only Arab leader to criticize Syria's actions. In late 1972 and early 1973, Libya invaded Chad to annex the uranium-rich Aouzou Strip. Intent on propagating Islam, in 1973 Gaddafi founded the Islamic Call Society, which had opened 132 centres across Africa within a decade. In 1973 he converted Gabonese President Omar Bongo, an action which he repeated three years later with Jean-Bédel Bokassa, president of the Central African Republic.
=== Cor–Cz === Robert Corey (1897–1971). American protein chemist at Caltech, known for work with Linus Pauling on the α-helix and β-sheet. Member Natl. Acad. Sci. USA. Carl Ferdinand Cori (1896–1984). American biochemist at Washington University and Albert Einstein College of Medicine, who worked on glycogen. Nobel Prize in Physiology or Medicine (1947). Member Natl. Acad. Sci. USA. Gerty Cori (1896–1957). Czech-American biochemist at Washington University, known for glycogen research. Nobel Prize in Physiology or Medicine (1947). Athel Cornish-Bowden (b. 1943). British enzymologist at the CNRS, Marseille. He has contributed to the development of metabolic control analysis, and is the author of Fundamentals of Enzyme Kinetics. Suzanne Cory (b. 1942). Australian molecular biologist known fotr work on the genetics of the immune system, at the Walter and Eliza Hall Institute of Medical Research, Melbourne. Peter Coveney (b. 1958). British Computational molecular biology specialist at University College London, University of Amsterdam and Yale. Nicholas R. Cozzarelli (1938–2006). American biochemist at UC Berkeley, and former editor-in-chief of the Proceedings of the National Academy of Sciences. Member Natl. Acad. Sci. USA. Gerald Crabtree (b. 1946). American biochemist at Stanford, known for defining the Ca2+-calcineurin-NFAT signalling pathway, pioneering the development of synthetic ligands for regulation of biological processes. Robert K. Crane (1919–2010).
=== Oxidative stability === Using differential scanning calorimetry to study the stability to oxidation of samples generally requires an airtight sample chamber. It can be used to determine the oxidative-induction time (OIT) of a sample. Such tests are usually done isothermally (at constant temperature) by changing the atmosphere of the sample. First, the sample is brought to the desired test temperature under an inert atmosphere, usually nitrogen. Oxygen is then added to the system. Any oxidation that occurs is observed as a deviation in the baseline. Such analysis can be used to determine the stability and optimum storage conditions for a material or compound. DSC equipment can also be used to determine the Oxidative-Onset Temperature (OOT) of a material. In this test a sample (and a reference) are exposed to an oxygen atmosphere and subjected to a constant rate of heating (typically from 50 to 300 °C). The DSC heat flow curve will deviate when the reaction with oxygen begins (the reaction being either exothermic or endothermic). Both OIT and OOT tests are used as a tools for determining the activity of antioxidants.
Sources: en.wikipedia.org
He concluded his speech by saying that "great rejuvenation of the Chinese nation and making America great again can go hand in hand" and that "Let us meet the people's expectations and show our historical initiative, let us keep advancing the cause of friendship between our two peoples and work together to build a better world".
=== Precursor to other peroxide compounds === Hydrogen peroxide is a weak acid, forming hydroperoxide or peroxide salts with many metals. It also converts metal oxides into the corresponding peroxides. For example, upon treatment with hydrogen peroxide, chromic acid (CrO3 and H2SO4) forms a blue peroxide CrO(O2)2.
=== IISB - ISCEA International Standards Board === From 2005 to 2020 Mr. Mike Sheahan, former International President of APICS, served as President of ISCEA International Standards Board (IISB). On June 30, 2020, Mr. Sheahan became "President Emeritus" and Dr. Erick C. Jones became "President-Elect", assuming the IISB leadership role. Dr. Jones has been in the IISB Board of Directors since 2005 and is currently Chair of the IISB Technology Committee, Engineering Research Center Program Director at the National Science Foundation, Editor in Chief of the International Supply Chain Technology Journal (ISCTJ), the George and Elizabeth Pickett Endowed Professor in the Department of Industrial and Manufacturing Systems Engineering (IMSE) and Associate Dean for Graduate Studies in the College of Engineering at the University of Texas at Arlington. ISCEA International Standards Board members also include Justin Goldston, Professor & Coordinator of Project and Supply Chain Management at Penn State University, Dr. Charles A. Watts, executive director of Education and Certification Programs at ISCEA and also Professor in the Department of Management, Marketing, and Logistics at John Carroll University; Dr. Kenneth Paetsch, former professor of Cleveland State University (CSU) and the University of Illinois Springfield (UIS); Dr.
== Etymology == The English word "tofu" comes from Japanese tōfu (豆腐, see below), which in turn borrows Chinese 豆腐 (Mandarin: dòufǔ or tòufu) 'bean ferment'. The earliest documentation of the word in English is in the 1704 translation of Domingo Fernández Navarrete's A Collection of Voyages and Travels, that describes how tofu was made. The word towfu also appears in a 1770 letter from the English merchant James Flint to Benjamin Franklin. The term "bean curd(s)" for tofu has been used in the United States since at least 1840.
Sources: en.wikipedia.org
It is a synthetic pentapeptide belonging to the growth hormone secretagogue family. Its principal characterized target is the ghrelin receptor, also called GHS-R1a. The molecule contains non-natural amino acids and an amidated C-terminus.
Both act at the same G protein-coupled receptor, but ipamorelin is a short synthetic peptide with modified residues rather than the natural 28-amino-acid hormone. Reports describe weaker effects on appetite and on cortisol or prolactin release than those seen with ghrelin. Its resistance to enzymatic breakdown also differs from that of the natural ligand.
Receptor binding and downstream calcium signaling are well characterized in cell-based systems. Effects measured in whole organisms are less consistent across studies and species. The extent to which selective receptor behavior drives the observed hormonal profile is still debated.
The peptide is Aib-His-D-2-Nal-D-Phe-Lys-NH2. Two of its residues are non-natural, which slows enzymatic degradation. The C-terminal amide is common among bioactive peptides.